TRDA

ENTRADA THERAPEUTICS INC

Healthcare | Small Cap

-$1.01

EPS Forecast

$6.21

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$1.01

Revenue Forecast:

$6.21

EPS Surprise Forecast:

$0.048

Revenue Surprise Forecast:

-$0

Post-release price volatility - High

Post-release Overnight Move:

±7.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

63%

Probability of beating revenue consensus:

50%

Probability of beating both EPS & revs consensus:

37%

Probability of missing both EPS & revs consensus:

24%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.58

Earnings volatility

EPS standard deviation:

$0.35

Revenue standard deviation:

$7

As % of share price:

2.92% VERY HIGH

As % of market cap:

1.61% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.59

Revenue 95th %ile:

$15

EPS 75th %ile:

-$0.90

Revenue 75th %ile:

$8

EPS 25th %ile:

-$1.12

Revenue 25th %ile:

$4

EPS 5th %ile:

-$1.44

Revenue 5th %ile:

-$1

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

67% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$60

Bid-ask per Share:

$0.07